Shares of Autodesk (ADSK) have gained 6% over the past four weeks to close the last trading session at $257.89, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $340.96 indicates a potential upside of 32.2%.

The average comprises 26 short-term price targets ranging from a low of $279.00 to a high of $460.00, with a standard deviation of $39.29. While the lowest estimate indicates an increase of 8.2% from the current price level, the most optimistic estimate points to an 78.4% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

However, an impressive consensus price target is not the only factor that indicates a potential upside in ADSK. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You May Not Know About Analysts' Price Targets

According to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

SS&C Technologies (SSNC) closed the last trading session at $74.78, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $100.13 indicates a 33.9% upside potential.

The average comprises eight short-term price targets ranging from a low of $86.00 to a high of $112.00, with a standard deviation of $8.27. While the lowest estimate indicates an increase of 15% from the current price level, the most optimistic estimate points to a 49.8% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

But, for SSNC, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You Should Know About Analysts' Price Targets

According to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

Globe Life Inc. (NYSE:GL) is one of the Top 10 Stocks Warren Buffett Would Buy in 2026.

On February 25, 2026, Wells Fargo analyst Elyse Greenspan raised the price target on Globe Life Inc. (NYSE:GL) from $170 to $171 while keeping an Overweight rating on the shares. The firm is lowering earnings estimates for most companies following fourth-quarter guidance that matched or trailed consensus expectations. Wells Fargo is also aligning its valuation models with 2027 earnings and introducing initial estimates for 2028, signaling more extensive coverage in long-term financial forecasting for the sector.

In another event, on February 9, 2026, Globe Life Inc. (NYSE:GL) noted significant insider activity. The company’s Executive Vice President and Chief Strategy Officer, Michael Clay Majors, disclosed a sale of 30,000 shares of the company’s stock. The transaction, valued at $4,406,655, resulted in a -39% change in Michael’s ownership stake in Globe Life Inc. (NYSE:GL).

According to CNN, 69% of 13 analysts covering the stock have assigned a Buy rating as of February 27, 2026, with a 1-year median price target of $171.

Founded in 1900, Globe Life Inc. (NYSE:GL) is a provider of life and supplemental health insurance for middle-income families with headquarters in Texas.

While we acknowledge the potential of GL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Stocks to Buy in 2026 According to Reddit and 13 High-Quality S&P 500 Financial Stocks According to Hedge Funds.

Disclosure. None. Follow Insider Monkey on Google News.

Shares of LiveOne (LVO) have gained 0.6% over the past four weeks to close the last trading session at $5.16, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $11.5 indicates a potential upside of 122.9%.

The mean estimate comprises four short-term price targets with a standard deviation of $1.91. While the lowest estimate of $10.00 indicates a 93.8% increase from the current price level, the most optimistic analyst expects the stock to surge 171.3% to reach $14.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

But, for LVO, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You Should Know About Analysts' Price Targets

According to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

​Willis Towers Watson Public Limited Company (NASDAQ:WTW) is one of the Best Undervalued UK Stocks to Invest In. On February 27, Mizuho analyst Yaron Kinar lowered the firm’s price target on the stock from $392 to $358, while maintaining a Buy rating. Earlier, on February 26, Bob Huang from Morgan Stanley reiterated a Hold rating on Willis Towers Watson Public Limited Company (NASDAQ:WTW) and lowered the price target from $345 to $330.

​Yaron Kinar from Mizuho said in a research note that the price target adjustment is based on the recent selloff in the insurance property and casualty sector. The firm views AI as a low disruption threat for insurance brokerages such as Willis Towers Watson, which target middle-market and larger accounts. The firm noted that disintermediation risks from AI are instead concentrated in mass-market personal lines and small-to-medium enterprise (SME) segments.

​Similarly, Huang from Morgan Stanley noted that the updated price target follows the Q4 reports in the property and casualty insurance group. The firm believes that Insurers with differentiated underwriting performance are positioned to post stronger share price gains. The positive outlook for differentiated underwriters comes despite weak pricing and ongoing AI headwinds.

​Willis Towers Watson Public Limited Company (NASDAQ:WTW) is a global advisory, broking, and solutions company focused on delivering data-driven insights for managing people, risk, and capital.

While we acknowledge the potential of WTW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Follow Insider Monkey on Google News.

Reinsurance Group of America, Incorporated (NYSE:RGA) is among the 11 Cheap Growth Stocks to Buy Right Now.

On March 3, 2026, Morgan Stanley raised the price target on Reinsurance Group of America, Incorporated (NYSE:RGA) to $223 from $208 and maintained an Equal Weight rating. Morgan Stanley said the update comes as the firm revises price targets across its Insurance – Life/Annuity North America coverage. Morgan Stanley added that while exposure to private credit is not viewed as a concern for life insurers, valuation pressure could still emerge across the broader industry.

On February 25, 2026, Wells Fargo raised its price target on Reinsurance Group to $261 from $238 and maintained an Overweight rating. Wells Fargo said that after Q4 guidance from most companies, the firm is generally lowering EPS estimates as outlooks came in in line with or below consensus for much of the group. Wells Fargo also said it is rolling valuation methodologies to 2027 EPS and introducing new 2028E EPS estimates.

Earlier in February, Reinsurance Group reported Q4 adjusted EPS of $7.75 versus consensus of $5.75 and revenue of $6.64B compared with consensus of $6.34B. President and Chief Executive Officer Tony Cheng highlighted a “very strong fourth quarter,” citing positive contributions across most business segments and describing the results as evidence of the company’s diversified global platform.

Reinsurance Group of America, Incorporated (NYSE:RGA) provides life and health and asset-intensive reinsurance services across the United States, Latin America, Canada, Europe, the Middle East, Africa, Asia, and Australia.

While we acknowledge the potential of RGA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Tech Stocks that Beat Earnings Estimates and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026

Disclosure: None. Follow Insider Monkey on Google News.

Prothena (PRTA) closed the last trading session at $9.4, gaining 5.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $20.5 indicates an 118.1% upside potential.

The mean estimate comprises six short-term price targets with a standard deviation of $10.65. While the lowest estimate of $8.00 indicates a 14.9% decline from the current price level, the most optimistic analyst expects the stock to surge 283% to reach $36.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice.

But, for PRTA, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You May Not Know About Analysts' Price Targets

According to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.